Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation
Open Access
- 4 May 2011
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (11) , 1646-1652
- https://doi.org/10.1016/j.bbmt.2011.04.011
Abstract
No abstract availableKeywords
Funding Information
- Division of Oncology and the Mentors in Medicine program
- NCI CCC (P30 CA091842)
This publication has 23 references indexed in Scilit:
- Predictive value of early 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high‐dose chemotherapyBritish Journal of Haematology, 2009
- Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphomaAnnals of Oncology, 2008
- Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish StudyJournal of Clinical Oncology, 2007
- Therapy of Relapsed Hodgkin LymphomaBlood Reviews, 2007
- Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphomaCancer, 2007
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s LymphomaTransplantation and Cellular Therapy, 2006
- Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patientsAnnals of Oncology, 2004
- New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin's Lymphoma Registered in the Database of the German Hodgkin's Lymphoma Study GroupJournal of Clinical Oncology, 2002